← Back to Clinical Trials
Recruiting NCT07021053

NCT07021053 Adaptive Actions and Alcohol Use Outcomes During Internet-delivered Cognitive Behaviour Therapy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07021053
Status Recruiting
Phase
Sponsor University of Regina
Condition Alcohol Misuse
Study Type INTERVENTIONAL
Enrollment 165 participants
Start Date 2025-05-14
Primary Completion 2026-05-14

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Alcohol Change Course Enhanced

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 165 participants in total. It began in 2025-05-14 with a primary completion date of 2026-05-14.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This observational study investigates an Internet-delivered Cognitive Behaviour Therapy (ICBT) intervention for alcohol misuse, called the Alcohol Change Course Enhanced (ACCE). The intervention will be offered through the Online Therapy Unit, which is a routine care ICBT clinic. The primary objective of the study is to examine whether engagement in adaptive actions measured by the Things You Do Questionnaire (TYDQ), including healthy thinking, meaningful activities, social connections, healthy habits and goal setting - increase during ICBT for alcohol misuse. Using data collected during routine care, the relationship between adaptive actions and alcohol use will be investigated, and specifically explore if the frequency of adaptive actions increases as alcohol use reduces during the intervention.

Eligibility Criteria

Inclusion Criteria: * Be a resident of Canada * Be 18 years or older * Have access to a computer or appropriate device and the internet * Endorse alcohol misuse Exclusion Criteria: * Current severe medical or psychiatric problem that requires immediate or alternate treatment (e.g. current and recent mania or psychosis requiring hospitalization, actively suicidal and unable to keep themselves safe, medical condition requiring immediate surgery or other invasive treatment, severe substance use, severe cognitive impairment); * Currently receiving or expecting to receive individual alcohol treatment more than twice per month * Other treatment in our clinic * Unable to read and understand English. (All content is provided in English and staff is English speaking; it is cost prohibitive at this time to provide the complete service in languages other than English)

Contact & Investigator

Central Contact

Marcie Nugent, MSW

✉ marcie.nugent@uregina.ca

📞 306-337-3331

Principal Investigator

Heather Hadjistavropoulos, PhD

PRINCIPAL INVESTIGATOR

University of Regina

Frequently Asked Questions

Who can join the NCT07021053 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Alcohol Misuse. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07021053 currently recruiting?

Yes, NCT07021053 is actively recruiting participants. Contact the research team at marcie.nugent@uregina.ca for enrollment information.

Where is the NCT07021053 trial being conducted?

This trial is being conducted at Regina, Canada.

Who is sponsoring the NCT07021053 clinical trial?

NCT07021053 is sponsored by University of Regina. The principal investigator is Heather Hadjistavropoulos, PhD at University of Regina. The trial plans to enroll 165 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology